IMPURITY-2;(S)-N-[[-(3-(3-FLUORO-4-(4-MORPHOLINYL)-PHENYL]-2-OXO-5-OXAZOLIDINYL]-METHYL]-CHLORIDE
Compound with spectra: 1 NMR
![IMPURITY-2;(S)-N-[[-(3-(3-FLUORO-4-(4-MORPHOLINYL)-PHENYL]-2-OXO-5-OXAZOLIDINYL]-METHYL]-CHLORIDE](/api/compound/7bT4VeuqKzd.png?ph=true&h=300&w=458 "IMPURITY-2;(S)-N-[[-(3-(3-FLUORO-4-(4-MORPHOLINYL)-PHENYL]-2-OXO-5-OXAZOLIDINYL]-METHYL]-CHLORIDE")
| SpectraBase Compound ID | 7bT4VeuqKzd |
|---|---|
| InChI | InChI=1S/C14H16ClFN2O3/c15-8-11-9-18(14(19)21-11)10-1-2-13(12(16)7-10)17-3-5-20-6-4-17/h1-2,7,11H,3-6,8-9H2/t11-/m0/s1 |
| InChIKey | IZNZPAMEUUTJRA-NSHDSACASA-N |
| Mol Weight | 314.74 g/mol |
| Molecular Formula | C14H16ClFN2O3 |
| Exact Mass | 314.083348 g/mol |
| Enantiomer InChIKey | IZNZPAMEUUTJRA-LLVKDONJSA-N |
| Racemate InChIKey | IZNZPAMEUUTJRA-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(R)-[N-3-[3-Fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl]methanol
5-(aminomethyl)-3-(3,5-difluoro-4-pyridin-3-ylphenyl)-1,3-oxazolidin-2-one
(phenylmethyl) N-(3-fluoranyl-4-pyridin-4-yl-phenyl)-N-prop-2-enyl-carbamate
4-[2-fluoro-5-(4-methyl-1-piperidinyl)-4-nitrophenyl]morpholine
(phenylmethyl) N-[3,5-bis(fluoranyl)-4-pyridin-3-yl-phenyl]-N-prop-2-enyl-carbamate
1(2H)-Quinolinecarboxylic acid, 3,4-dihydro-6-nitro-, methyl ester
Benzamide, 2-chloro-N-[[[4-(3,5-dimethyl-1-piperidinyl)-3-fluorophenyl]amino]carbonyl]-
morpholine, 4-[4-fluoro-2-nitro-5-(1-pyrrolidinyl)phenyl]-
1H-indole-1-carboxylic acid, 2,3-dihydro-5-nitro-, ethyl ester
(Z)-4-benzylidene-5,5-dimethyl-3-phenyloxazolidin-2-one
| Title | Journal or Book | Year |
|---|---|---|
| Isolation and characterization of process-related impurities in linezolid | Journal of Pharmaceutical and Biomedical Analysis | 2002 |